Seres Therapeutics, Inc. , a leading microbiome therapeutics company, today announced that on June 7, 2023, the Compensation and Talent Committee of Seres’ board of directors granted. | June 9, 2023
Seres Therapeutics, Inc. , a leading microbiome therapeutics company, today announced that on April 5, 2023, the Compensation and Talent Committee of Seres’ board of directors granted. | April 7, 2023